Advances in Understanding the Pharmacological Properties of Antisense Oligonucleotides
- 1 January 1997
- book chapter
- Published by Elsevier
- Vol. 40, 1-49
- https://doi.org/10.1016/s1054-3589(08)60136-2
Abstract
No abstract availableKeywords
This publication has 167 references indexed in Scilit:
- Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate oligonucleotides, following subacute intradermal administration in Sprague-Dawley ratsToxicology, 1997
- Antisense inhibition of hypertension: A new strategy for renin-angiotensin candidate genesKidney International, 1994
- Modulation of substance P/neurokinin-1 receptor in human astrocytoma cells by antisense oligodeoxynucleotidesGeneral Pharmacology: The Vascular System, 1994
- Suppression of Neointimal Smooth Muscle Cell Accumulation in Vivo by Antisense cdc2 and cdk2 Oligonucleotides in Rat Carotid ArteryBiochemical and Biophysical Research Communications, 1994
- Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virusLife Sciences, 1994
- Antisense oligonucleotides made of 2'‐O‐alkylRNA: their properties and applications in RNA biochemistryFEBS Letters, 1993
- Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brainEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Alkyl phosphotriesters of dinucleotides and oligonucleotides. 5. Inhibitory effect of complex formation with oligodeoxyribonucleotide ethyl phosphotriesters on transfer ribonucleic acid aminoacylationBiochemistry, 1974
- Synthesis and coding properties of poly(c1A), poly(c3A), poly(c7A) and poly(h6A)Biochemical and Biophysical Research Communications, 1973
- A quantitative assay for DNA-RNA hybrids with DNA immobilized on a membraneJournal of Molecular Biology, 1965